Novo Nordisk
NVO
#95
Rank
NZ$355.41 B
Marketcap
NZ$80.27
Share price
6.23%
Change (1 day)
-30.98%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report